Universe Pharmaceuticals INC
UPC
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.1M
Close$
$-3.45
172.3% downside
Current Fair Value
172.3% downsideOvervalued by 172.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.10 Million |
|---|---|
| Enterprise Value | $-14,868,596.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1055.75 |
| Beta | 1.53 |
| Outstanding Shares | 563,338 |
Return
| Return on Equity | -1.53% |
|---|---|
| Return on Assets | -1.19% |
| Return on Invested Capital | -0.84% |
Valuation & Multiples
| P/E Ratio | -1.42 |
|---|---|
| PEG | 2.7 |
| Price to Sales | 0.07 |
| Price to Book Ratio | 0.05 |
| Enterprise Value to Revenue | -0.4 |
| Enterprise Value to EBIT | 30.79 |
| Enterprise Value to Net Income | 17 |
| Total Debt to Enterprise | -0.65 |
| Debt to Equity | 0.17 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
April 22, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 27.20%▼ 30.33% |
|---|---|
| Total Invested | $3,604▼ 60.15% |
| Investors Holding | 1▼ 1.00% |
ESG Score
No data
About Universe Pharmaceuticals INC
Universe Pharmaceuticals INC, headquartered in Ji’an, Jiangxi, China, is a pharmaceutical producer and distributor in China. The Company specializes in the manufacturing, marketing, sales and distribution of traditional Chinese medicine ...